drugset
drugset / Trial / NCT04213885

Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position

NCT04213885 ↗

Phase 2 Completed 12 enrolled Eye Specialists of Indiana
RandomizedSequentialSingle-blindTreatment

Summary

To determine whether the Peschke PXL-330 is safe and effective in the treatment of corneal thinning conditions.

Timeline

Start
2020-05-04
Primary completion
2024-08-05
Completion
2024-08-05

Drugs

EvaluationDrugModalityDoseRoute
Background Riboflavin Other / unclassified — —

Indications

corneal ectasia keratitis keratoconus